Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Nutrient profiling for product reformulation: public health impact and benefits for the consumer.

Lehmann U, Charles VR, Vlassopoulos A, Masset G, Spieldenner J.

Proc Nutr Soc. 2017 Aug;76(3):255-264. doi: 10.1017/S0029665117000301. Epub 2017 Apr 19. Review.

PMID:
28420455
2.

Maternal nutrition: opportunities in the prevention of gestational diabetes.

Silva-Zolezzi I, Samuel TM, Spieldenner J.

Nutr Rev. 2017 Jan;75(suppl 1):32-50. doi: 10.1093/nutrit/nuw033. Review.

3.

Dietary strategies for improving iron status: balancing safety and efficacy.

Prentice AM, Mendoza YA, Pereira D, Cerami C, Wegmuller R, Constable A, Spieldenner J.

Nutr Rev. 2017 Jan;75(1):49-60. Review.

4.

The Role of Food Fortification in Addressing Iron Deficiency in Infants and Young Children.

Spieldenner J.

World Rev Nutr Diet. 2016;115:211-23. doi: 10.1159/000442107. Epub 2016 May 19. Review.

PMID:
27198518
5.

A nutrient profiling system for the (re)formulation of a global food and beverage portfolio.

Vlassopoulos A, Masset G, Charles VR, Hoover C, Chesneau-Guillemont C, Leroy F, Lehmann U, Spieldenner J, Tee ES, Gibney M, Drewnowski A.

Eur J Nutr. 2017 Apr;56(3):1105-1122. doi: 10.1007/s00394-016-1161-9. Epub 2016 Feb 15.

6.

Industry Approach to Nutrition-Based Product Development and Reformulation in Asia.

Vlassopoulos A, Masset G, Leroy F, Spieldenner J.

J Nutr Sci Vitaminol (Tokyo). 2015;61 Suppl:S187-8. doi: 10.3177/jnsv.61.S187.

7.

Increased Intake of Foods with High Nutrient Density Can Help to Break the Intergenerational Cycle of Malnutrition and Obesity.

Troesch B, Biesalski HK, Bos R, Buskens E, Calder PC, Saris WH, Spieldenner J, Verkade HJ, Weber P, Eggersdorfer M.

Nutrients. 2015 Jul 21;7(7):6016-37. doi: 10.3390/nu7075266. Review.

8.

Health Economics and Nutrition: Atopic Dermatitis. Editorial.

Spieldenner J, Koletzko S.

Ann Nutr Metab. 2015;66 Suppl 1:5-6. doi: 10.1159/000375331. Epub 2015 Apr 24. No abstract available.

9.

Cost-effectiveness of partially-hydrolyzed formula for prevention of atopic dermatitis in Australia.

Su J, Prescott S, Sinn J, Tang M, Smith P, Heine RG, Spieldenner J, Iskedjian M.

J Med Econ. 2012;15(6):1064-77. doi: 10.3111/13696998.2012.697085. Epub 2012 Jun 12. Erratum in: J Med Econ. 2012;15(6):1077.

PMID:
22630113
10.

Partially hydrolysed 100% whey-based infant formula and the prevention of atopic dermatitis: comparative pharmacoeconomic analyses.

Spieldenner J, Belli D, Dupont C, Haschke F, Iskedjian M, Nevot Falcó S, Szajewska H, von Berg A.

Ann Nutr Metab. 2011;59 Suppl 1:44-52. doi: 10.1159/000334232. Epub 2011 Dec 21. Review.

11.

Economic evaluation of a 100% whey-based partially hydrolyzed infant formula in the prevention of atopic dermatitis among Danish children.

Iskedjian M, Haschke F, Farah B, van Odijk J, Berbari J, Spieldenner J.

J Med Econ. 2012;15(2):394-408. doi: 10.3111/13696998.2011.650528. Epub 2012 Jan 17.

PMID:
22171936
12.

Economic evaluation of a 100% whey-based, partially hydrolysed formula in the prevention of atopic dermatitis among French children.

Iskedjian M, Dupont C, Spieldenner J, Kanny G, Raynaud F, Farah B, Haschke F.

Curr Med Res Opin. 2010 Nov;26(11):2607-26. doi: 10.1185/03007995.2010.525472. Epub 2010 Oct 6.

PMID:
20925454
13.

Meta-analysis of a partially hydrolysed 100%-whey infant formula vs. extensively hydrolysed infant formulas in the prevention of atopic dermatitis.

Iskedjian M, Szajewska H, Spieldenner J, Farah B, Berbari J.

Curr Med Res Opin. 2010 Nov;26(11):2599-606. doi: 10.1185/03007995.2010.525475. Epub 2010 Oct 6.

PMID:
20925453
14.

Health economic perspectives of pediatric malnutrition: determinants of innovative progress.

Spieldenner J.

Nestle Nutr Workshop Ser Pediatr Program. 2010;66:97-109. doi: 10.1159/000318951. Epub 2010 Jul 21.

PMID:
20664219

Supplemental Content

Loading ...
Support Center